- Home
- ISPO vs DTIL Comparison
ISPO vs DTIL Comparison
Compare ISPO & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- DTIL
- Stock Information
- Founded
- ISPO 2010
- DTIL 2006
- Country
- ISPO United States
- DTIL United States
- Employees
- ISPO N/A
- DTIL N/A
- Industry
- ISPO Blank Checks
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- ISPO Finance
- DTIL Health Care
- Exchange
- ISPO Nasdaq
- DTIL Nasdaq
- Market Cap
- ISPO 39.0M
- DTIL 44.1M
- IPO Year
- ISPO N/A
- DTIL 2019
- Fundamental
- Price
- ISPO $6.99
- DTIL $4.96
- Analyst Decision
- ISPO Buy
- DTIL Strong Buy
- Analyst Count
- ISPO 2
- DTIL 3
- Target Price
- ISPO $10.50
- DTIL $37.67
- AVG Volume (30 Days)
- ISPO 71.9K
- DTIL 1.3M
- Earning Date
- ISPO 03-04-2025
- DTIL 11-04-2024
- Dividend Yield
- ISPO N/A
- DTIL N/A
- EPS Growth
- ISPO N/A
- DTIL N/A
- EPS
- ISPO N/A
- DTIL 1.45
- Revenue
- ISPO $287,451,000.00
- DTIL $75,096,000.00
- Revenue This Year
- ISPO N/A
- DTIL $52.95
- Revenue Next Year
- ISPO N/A
- DTIL N/A
- P/E Ratio
- ISPO N/A
- DTIL $2.57
- Revenue Growth
- ISPO N/A
- DTIL 43.62
- 52 Week Low
- ISPO $3.11
- DTIL $3.61
- 52 Week High
- ISPO $9.31
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- ISPO 87.48
- DTIL 46.54
- Support Level
- ISPO $3.26
- DTIL $5.10
- Resistance Level
- ISPO $3.75
- DTIL $7.44
- Average True Range (ATR)
- ISPO 0.49
- DTIL 0.66
- MACD
- ISPO 0.31
- DTIL 0.14
- Stochastic Oscillator
- ISPO 95.40
- DTIL 35.25
About ISPO Inspirato Incorporated
Inspirato Inc is a luxury travel subscription luxury travel company that provides exclusive access to a managed and controlled portfolio of curated vacation options, delivered through a model designed to ensure the service, certainty, and value that discerning customers demand. The Inspirato portfolio includes branded luxury vacation homes, accommodations at five-star hotel and resort partners, and custom travel experiences. It has a geographic location in the United States and Outside the United States. It generates the majority of its revenue from the United States.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.